Nitric Oxide and Cyclic GMP in Cell Signaling and Drug Development
暂无分享,去创建一个
[1] E. Sutherland,et al. Formation of a cyclic adenine ribonucleotide by tissue particles. , 1958, The Journal of biological chemistry.
[2] F. Murad,et al. Adenyl cyclase. III. The effect of catecholamines and choline esters on the formation of adenosine 3',5'-phosphate by preparations from cardiac muscle and liver. , 1962, The Journal of biological chemistry.
[3] R. Butcher,et al. Adenosine 3',5'-phosphate in biological materials. I. Purification and properties of cyclic 3',5'-nucleotide phosphodiesterase and use of this enzyme to characterize adenosine 3',5'-phosphate in human urine. , 1962, The Journal of biological chemistry.
[4] M. Melicow,et al. Isolation of adenosine 3', 5'-monophosphate and guanosine 3', 5'-monophosphate from rat urine. , 1963, Biochemical and biophysical research communications.
[5] F. Murad,et al. Evidence for two different forms of guanylate cyclase in rat heart. , 1974, The Journal of biological chemistry.
[6] F. Murad,et al. Two forms of guanylate cyclase in mammalian tissues and possible mechanisms for their regulation. , 1975, Metabolism: clinical and experimental.
[7] F. Murad,et al. Activation of guanylate cyclase from rat liver and other tissues by sodium azide. , 1975, The Journal of biological chemistry.
[8] F. Murad,et al. Increases in cyclic GMP levels in brain and liver with sodium azide an activator of guanylate cyclase , 1975, Nature.
[9] F. Murad,et al. Purification and properties of a protein required for sodium azide activation of guanylate cyclase. , 1977, The Journal of biological chemistry.
[10] F. Murad,et al. Nitric oxide activates guanylate cyclase and increases guanosine 3':5'-cyclic monophosphate levels in various tissue preparations. , 1977, Proceedings of the National Academy of Sciences of the United States of America.
[11] F. Murad,et al. Formation of adenosine 3':5'-monophosphate by preparations of guanylate cyclase from rat liver and other tissues. , 1977, The Journal of biological chemistry.
[12] F. Murad,et al. Cigarette smoke activates guanylate cyclase and increases guanosine 3',5'-monophosphate in tissues. , 1977, Science.
[13] F. Murad,et al. Effects of sodium nitroprusside, nitroglycerin, and sodium azide on levels of cyclic nucleotides and mechanical activity of various tissues. , 1977, Journal of cyclic nucleotide research.
[14] F. Murad,et al. Guanylate cyclase: activation by azide, nitro compounds, nitric oxide, and hydroxyl radical and inhibition by hemoglobin and myoglobin. , 1978, Advances in cyclic nucleotide research.
[15] F. Murad,et al. Effect of Nitro-Compound Smooth Muscle Relaxants and Other Materials on Cyclic GMP Metabolism , 1979 .
[16] F. Murad,et al. Synthesis of adenosine 3',5'-monophosphate by guanylate cyclase, a new pathway for its formation. , 1979, Biochimica et biophysica acta.
[17] R. Furchgott,et al. The obligatory role of endothelial cells in the relaxation of arterial smooth muscle by acetylcholine , 1980, Nature.
[18] T. Deguchi,et al. L-Arginine identified as an endogenous activator for soluble guanylate cyclase from neuroblastoma cells. , 1982, The Journal of biological chemistry.
[19] F. Murad,et al. Agonist‐Induced Endothelium‐Dependent Relaxation in Rat Thoracic Aorta May Be Mediated through cGMP , 1983, Circulation research.
[20] Robert M. Rapoport,et al. Endothelium-dependent relaxation in rat aorta may be mediated through cyclic GMP-dependent protein phosphorylation , 1983, Nature.
[21] F. Murad,et al. Cyclic guanosine monophosphate as a mediator of vasodilation. , 1986, The Journal of clinical investigation.
[22] F. Murad,et al. Co-purification of an atrial natriuretic factor receptor and particulate guanylate cyclase from rat lung. , 1986, The Journal of biological chemistry.
[23] F. Murad,et al. Soluble guanylate cyclase from rat lung exists as a heterodimer. , 1986, The Journal of biological chemistry.
[24] J. Hibbs,et al. Macrophage cytotoxicity: role for L-arginine deiminase and imino nitrogen oxidation to nitrite. , 1987, Science.
[25] J. T. Shepherd,et al. Vasodilatation : vascular smooth muscle, peptides, autonomic nerves, and endothelium , 1988 .
[26] F. Murad. Modulation of the Guanylate Cyclase -cGMP System by Vasodilators and the Role of Free Radicals as Second Messengers , 1989 .
[27] D. Garbers. Guanylyl cyclase-linked receptors. , 1991, Pharmacology & therapeutics.
[28] F. Murad. Cyclic GMP: synthesis, metabolism, and function. Introduction and some historical comments. , 1994, Advances in pharmacology.
[29] F. Murad. Introduction and Some Historical Comments , 1994 .
[30] J. Beavo,et al. Cyclic nucleotide phosphodiesterases: functional implications of multiple isoforms. , 1995, Physiological reviews.
[31] F. Murad,et al. Genomic organization of α1 and β1 subunits of the mammalian soluble guanylyl cyclase genes , 2000 .
[32] F. Murad,et al. Estradiol rapidly inhibits soluble guanylyl cyclase expression in rat uterus. , 2001, Proceedings of the National Academy of Sciences of the United States of America.
[33] F. Murad. Discovery of Some of the Biological Effects of Nitric Oxide and its Role in Cell Signaling , 1999, Bioscience reports.
[34] F. Murad,et al. Soluble guanylyl cyclase: the nitric oxide receptor. , 2005, Methods in enzymology.
[35] F. Murad,et al. Differential expression of genes involved in cGMP-dependent nitric oxide signaling in murine embryonic stem (ES) cells and ES cell-derived cardiomyocytes. , 2006, Nitric oxide : biology and chemistry.